Business Context and Reporting Period
Company: Brookdale Senior Living Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 21, 2014
Event Date: February 20, 2014
Context: Brookdale Senior Living Inc. entered into a definitive Agreement and Plan of Merger to acquire Emeritus Corporation. The transaction involves a stock-for-stock exchange where Emeritus will become a wholly-owned subsidiary of Brookdale.
Key Financial Metrics and Transaction Terms
This filing details a merger agreement rather than periodic financial performance. Key financial terms include:
- Exchange Ratio: 0.95 shares of Brookdale Common Stock for each share of Emeritus Common Stock.
- Termination Fees:
- Brookdale to pay Emeritus: $143 million (under specified circumstances, including Superior Proposal).
- Emeritus to pay Brookdale: $53 million (under specified circumstances).
- Stockholder Approval Failure Fee: $13.5 million payable by the party whose stockholders fail to approve.
- Capital Structure Change: Brookdale seeks approval to increase authorized shares from 200,000,000 to 500,000,000.
- Option Treatment: Emeritus options with exercise prices below the implied merger value will be converted to Brookdale stock; others will be canceled.
Note: The filing text does not provide specific revenue, profit, cash flow, margin, or debt figures for either company.
Material Changes and Conditions
The primary material change is the execution of the Merger Agreement. The closing of the transaction is subject to several conditions, including:
- Approval by stockholders of both Brookdale and Emeritus.
- Expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act.
- Receipt of necessary federal and state government approvals for facility ownership and operation.
- Limitation on dissenting shares (no more than 7.5% of Emeritus shares).
- Absence of a "Material Adverse Effect" on either party.
Outlook, Risks, and Management Commentary
Management Actions:
- Brookdale and Emeritus have agreed to use reasonable best efforts to consummate the merger.
- Granger Cobb, CEO of Emeritus, is expected to join Brookdale's board of directors post-closing and provide consulting services.
- Voting agreements were executed with certain Emeritus stockholders and Fortress Investment Group affiliates to support the transaction.
- Regulatory Risk: Failure to obtain antitrust or facility-specific approvals.
- Stockholder Risk: Failure of either party's stockholders to approve the deal.
- Market Risk: Global economic conditions, capital market liquidity, and interest rate changes.
- Operational Risk: Integration difficulties, inability to realize synergies, and changes in senior housing demand.
- Termination Risk: The agreement may be terminated if closing does not occur within nine months (extendable by 60 days) or if a Superior Proposal is received.
Investor Verification Checklist
- Verify the final approval status of the merger by both Brookdale and Emeritus stockholders.
- Monitor the status of regulatory approvals, specifically under the Hart-Scott-Rodino Act and state facility licenses.
- Review the upcoming Joint Proxy Statement/Prospectus (Form S-4) for detailed financial data and risk factors.
- Assess the potential impact of the $143 million termination fee obligation on Brookdale's liquidity if the deal fails due to a Superior Proposal.
- Confirm the final exchange ratio and any adjustments based on the volume-weighted average price of Brookdale stock at consummation.